New oral anticoagulants (NOAC) and liver injury

Journal of Hepatology

Volumn 61, Issue 2, 2014, Pages 198-199

  Moore, Nicholas ^a   Blin, Patrick ^a   Gulmez, Sinem Ezgi ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTICOAGULANT AGENT; ANTIVITAMIN K; APIXABAN; DABIGATRAN; ENOXAPARIN; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL; RIVAROXABAN; BLOOD CLOTTING FACTOR 10A INHIBITOR; MORPHOLINE DERIVATIVE; THIOPHENE DERIVATIVE;

BLEEDING; BRAIN HEMORRHAGE; DATA BASE; DRUG SURVEILLANCE PROGRAM; EDITORIAL; EPIDEMIOLOGY; FORWARD HEART FAILURE; HUMAN; LIVER INJURY; LIVER TOXICITY; META ANALYSIS; PRIORITY JOURNAL; TOTAL KNEE REPLACEMENT; WORLD HEALTH ORGANIZATION; DRUG-INDUCED LIVER INJURY; FEMALE; MALE;

DRUG-INDUCED LIVER INJURY; FACTOR XA INHIBITORS; FEMALE; HUMANS; MALE; MORPHOLINES; THIOPHENES;

EID: 84904756011     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2014.05.010     Document Type: Editorial

References (9)

1. S. Russmann, D.F. Niedrig, M. Budmiger, C. Schmidt, B. Stieger, and S. Hurlimann et al. Rivaroxaban postmarketing risk of liver injury J Hepatol 61 2014 293 300
2. S.E. Gulmez, D. Larrey, G.P. Pageaux, S. Lignot, R. Lassalle, and J. Jove et al. Transplantation for acute liver failure in patients exposed to NSAIDs or paracetamol (acetaminophen): the multinational case-population SALT study Drug Saf 36 2013 135 144
3. J.H. Lewis, D. Larrey, R. Olsson, W.M. Lee, L. Frison, and M. Keisu Utility of the Roussel Uclaf Causality Assessment Method (RUCAM) to analyze the hepatic findings in a clinical trial program: evaluation of the direct thrombin inhibitor ximelagatran Int J Clin Pharmacol Ther 46 2008 327 339
4. S.E. Gulmez, N. Moore, G.P. Pageaux, S. Lignot, Y. Horsmans, and B. Stricker et al. Causality of drugs involved in acute liver failure leading to transplantation: results from the Study of Acute Liver Transplant (SALT) Drug Saf 37 2014
5. N. Moore, S.E. Gulmez, D. Larrey, G.P. Pageaux, S. Lignot, and R. Lassalle et al. Choice of the denominator in case population studies: event rates for registration for liver transplantation after exposure to NSAIDs in the SALT study in France Pharmacoepidemiol Drug Saf 22 2013 160 167
6. S. Ehrenforth, J.F. Schenk, and I. Scharrer Liver damage induced by coumarin anticoagulants Semin Thromb Hemost 25 1999 79 83
7. M. Keisu, and T.B. Andersson Drug-induced liver injury in humans: the case of ximelagatran Handb Exp Pharmacol 2010 407 418
8. D. Caldeira, M. Barra, A.T. Santos, D. de Abreu, F.J. Pinto, and J.J. Ferreira et al. Risk of drug-induced liver injury with the new oral anticoagulants: systematic review and meta-analysis Heart 100 2014 550 556
9. P.B. Watkins, M. Desai, S.D. Berkowitz, G. Peters, Y. Horsmans, and D. Larrey et al. Evaluation of drug-induced serious hepatotoxicity (eDISH): application of this data organization approach to phase III clinical trials of rivaroxaban after total hip or knee replacement surgery Drug Saf 34 2011 243 252